JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis

JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis

Abstract Background JAK (Janus kinase) inhibitors work by inhibiting the activity of one or more of the enzyme Janus kinase with a therapeutic application for treatment of cancer and inflammatory disorders such as rheumatoid arthritis (RA). We aimed to study impact of JAK2 mutation in serum of rheum...

Full description

Bibliographic Details
Main Authors: Yasmin Adel, Mohamed Sabry, Amr Mohamed El-Sabbagh, Yousra Sadeq
Format: Article
Language:English
Published: SpringerOpen 2021-12-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Rheumatoid arthritis
JAK2 mutation
First line
Online Access:https://doi.org/10.1186/s43162-021-00089-2

Internet

https://doi.org/10.1186/s43162-021-00089-2

Similar Items